Hand Motor Rehabilitation Using a Wearable Robotic Device (WRL HX MCP)

Hand Motor Rehabilitation Using a Wearable Robotic Device (WRL HX MCP): a Pilot Study

The purpose of this pilot study is to assess the safety and usability of the WRL HX MCP medical device, a prototypal robotic system for metacarpophalangeal joint mobilization. WRL HX MCP was developed by the Wearable Robotics Laboratory of Scuola Superiore Sant'Anna in a project funded by and in collaboration with INAIL, to fulfil the needs of patients with post-traumatic hand stiffness.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study aims to:

  1. Test the safety and reliability of the WRL HX MCP device for assisting flexion and extension movement of the stiff metacarpophalangeal joint
  2. Conduct a preliminary examination of the efficacy of the device in the treatment of joint stiffness to design a subsequent RCT
  3. Evaluate the performance of the device in estimating the biomechanical parameters useful for the objective treatment outcome assessment.

Ten injured workers with post-traumatic and/or post-operative index finger MCP stiffness will be enrolled in a clinical trial consisting of one to four sessions of robotic therapy with WRL HX MCP at the INAIL Rehabilitation Center in Volterra.

Pilot testing of the experimental device will include the preliminary goniometric measure of passive and active MCP range of motion (ROM), the selection of the appropriate size of exoskeleton segments to fit user's anthropometry, the robotic assessment of ROM, force and torque trajectories of MCP joint, a program of robot-assisted passive and active MCF mobilization and a final clinical and robotic reassessment of joint ROM. The session will last about 1 hour and all exercises will be administered by a trained physical therapist supported by two members of the engineering team; pain level will be assessed at baseline and after each mobilization sequence; patient feedback will be recorded about the usability of the device in term of comfort, wearability, user safety, and overall satisfaction.

For Aim 1, the Safety and Reliability of the device will be evaluated in terms of the number of adverse events and malfunctions occurring during the study session.

For Aim 2, the efficacy of robot-assisted mobilization modes will be assessed by means of the longitudinal analysis of pre- and post-treatment measurements of MCP range of motion and pain intensity level, the flexion peak torque evaluation and the final administration of an ad-hoc satisfaction questionnaire.

For aim 3, the performance of WRL HX MCP will be studied by comparing the robotic MCP angle estimation with the measurements from a motion capture system.

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pisa
      • Volterra, Pisa, Italy, 56048
        • INAIL - Centro di Riabilitazione Motoria di Volterra

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • history of traumatic hand injury or post-traumatic hand surgery
  • hand size allowing to achieve proper exoskeleton fit
  • NRS pain score in the 1-5 range

Exclusion Criteria:

  • cognitive or linguistic ability insufficient to understand instructions
  • cardiac implanted electronic devices
  • open skin at the level of the patient-device interface
  • absence of contraindications for finger joints mobilisation
  • current or prior history of malignancy
  • pregnancy or breast feeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Robotic therapy
All participants will receive a program of robot-assisted rehabilitation exercises., including passive, active-assisive and active MCP Range-of-Motion Exercises, and active bidigital pinching movements in the transparent mode.
WRL HX MCP is a non CE marked class IIa medical device designed for clinical application in hand rehabilitation; it consists in a cable-driven robotic MCP orthosis providing flexion-extension of the metacarpo-phalangeal joint. WRL HX MCP features and a series-elastic actuators (SEA) architecture for compliant actuation of MCP flexion-extension and a self-aligning mechanism to absorb human/robot joint axes misplacement. Exoskeleton module is mounted on a dorsal hand support and connected to its electronic box through wires.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility indicator: completion of study procedures
Time Frame: through study completion, an average of 1 year
Percent of participants for whom study procedures were completed successfully
through study completion, an average of 1 year
Feasibility indicator: patient acceptability
Time Frame: After the robotic therapy session; the total expected time for the session is about 90 minutes.
Clinician-generated questionnaire to investigate patients' impressions about the physical interaction with the robotic device
After the robotic therapy session; the total expected time for the session is about 90 minutes.
Feasibility indicator: reliability evaluated through the number of device malfunctions
Time Frame: through study completion, an average of 1 year
The physiotherapist is required to report any malfunctions occurring during the study in regard to the use of WRL HX MCP
through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Goniometric measure of MCP Active Range of Motion (AROM)
Time Frame: at baseline and immediately after the robotic therapy session.
The physiotherapist measures the MCP joint angles in maximum active flexion and extension using a short-arm goniometer
at baseline and immediately after the robotic therapy session.
Goniometric measure of MCP Passive Range of Motion (PROM)
Time Frame: at baseline and immediately after the robotic therapy session
The physiotherapist measures the MCP joint angles in maximum passive flexion and extension using a short-arm goniometer
at baseline and immediately after the robotic therapy session
Robotic measure of MCP Active Range of Motion (AROM)
Time Frame: at baseline and immediately after the robotic therapy session
MCP joint maximum active flexion and extension range of motion is registered while the device and human joint are coupled together, using WRL HX MCP set in a transparent mode as an evaluation tool, without any manual assistance.
at baseline and immediately after the robotic therapy session
Robotic measure of MCP passive Range of Motion (PROM)
Time Frame: at baseline and immediately after the robotic therapy session
MCP joint maximum passive flexion and extension range of motion is registered while the device and human joint are coupled together, using WRL HX MCP set in a transparent mode as an evaluation tool, with manual assistance from the therapist.
at baseline and immediately after the robotic therapy session
Robotic estimation of MCP joint flexion peak torque
Time Frame: during robot-in-charge mobilization sequences
MCP joint flexion peak torque is evaluated by the exoskeleton torque joint sensor during the robot-in-charge mobilization sequences
during robot-in-charge mobilization sequences
Numeric Pain Rating Scale (NPRS)
Time Frame: at baseline and after each of the two series of joint mobilization exercises, lasting up to 30 minutes each.
NPRS is an 11-point scale for patient self-reporting of pain, with 0 being "no pain" and 10 being "the worst pain imaginable"
at baseline and after each of the two series of joint mobilization exercises, lasting up to 30 minutes each.
Safety evaluated through the number of adverse events
Time Frame: through study completion, an average of 1 year
The physiotherapist is required to report any adverse events occurring during the study in regard to the use of WRL HX MCP
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elisa Taglione, MD, INAIL - Centro di Riabilitazione Motoria di Volterra
  • Study Director: Simona Crea, PhD, The BioRobotics Institute, Scuola Superiore Sant'Anna

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 26, 2021

Primary Completion (Actual)

September 25, 2022

Study Completion (Actual)

March 25, 2023

Study Registration Dates

First Submitted

November 21, 2021

First Submitted That Met QC Criteria

December 9, 2021

First Posted (Actual)

December 13, 2021

Study Record Updates

Last Update Posted (Actual)

March 6, 2024

Last Update Submitted That Met QC Criteria

March 5, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hand Injuries

Clinical Trials on WRL HX MCP

Subscribe